These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3489627)

  • 1. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H; Mason MF; Debler EA; Lajtha A
    Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS; Abell CW; Gessner W; Brossi A
    FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA; Kindt MV; Heikkila RE
    J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I; Langston JW; DeLanney LE
    Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes as a primary locus for the conversion MPTP into MPP+.
    Brooks WJ; Jarvis MF; Wagner GC
    J Neural Transm; 1989; 76(1):1-12. PubMed ID: 2785159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA.
    Sershen H; Debler EA; Lajtha A
    J Neurosci Res; 1987; 17(3):298-301. PubMed ID: 3496464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
    Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG; Castagnoli N; Rollema H
    Neurosci Lett; 1989 May; 100(1-3):306-12. PubMed ID: 2788253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPTP, MPP+ and mitochondrial function.
    Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
    Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM; Arora PK; Iacofano LA; Harik SI
    Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
    Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
    J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
    Del Zompo M; Piccardi MP; Ruiu S; Quartu M; Gessa GL; Vaccari A
    Br J Pharmacol; 1993 Jun; 109(2):411-4. PubMed ID: 8102929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
    Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
    J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
    Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
    Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.